Literature DB >> 22773732

Spatial clusters of nontuberculous mycobacterial lung disease in the United States.

Jennifer Adjemian1, Kenneth N Olivier, Amy E Seitz, Joseph O Falkinham, Steven M Holland, D Rebecca Prevots.   

Abstract

RATIONALE: Prevalence of pulmonary nontuberculous mycobacterial (PNTM) disease varies by geographic region, yet the factors driving these differences remain largely unknown.
OBJECTIVES: To identify spatial clusters of PNTM disease at the county level and to describe environmental and sociodemographic factors predictive of disease.
METHODS: PNTM cases identified from a nationally representative sample of Medicare Part B beneficiaries from 1997 to 2007 were geocoded by county and state of residence. County-level PNTM case counts and Medicare population data were then uploaded into SaTScan to identify significant spatial clusters and low-risk areas of disease. High-risk and low-risk counties were then compared to identify significant sociodemographic and environmental differences.
MEASUREMENTS AND MAIN RESULTS: We identified seven significant (P < 0.05) clusters of PNTM cases. These high-risk areas encompassed 55 counties in 8 states, including parts of California, Florida, Hawaii, Louisiana, New York, Oklahoma, Pennsylvania, and Wisconsin. Five low-risk areas were also identified, which encompassed 746 counties in 23 states, mostly in the Midwest. Counties in high-risk areas were significantly larger, had greater population densities, and higher education and income levels than low-risk counties. High-risk counties also had higher mean daily potential evapotranspiration levels and percentages covered by surface water, and were more likely to have greater copper and sodium levels in the soil, although lower manganese levels.
CONCLUSIONS: Specific environmental factors related to soil and water exposure appear to increase the risk of PNTM infection. Still, given that environmental sources of NTM are ubiquitous and PNTM disease is rare, both host susceptibility and environmental factors must be considered in explaining disease development.

Entities:  

Mesh:

Year:  2012        PMID: 22773732      PMCID: PMC3480533          DOI: 10.1164/rccm.201205-0913OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.

Authors:  Kevin L Winthrop; Roger Baxter; Liyan Liu; Bentson McFarland; Donald Austin; Cara Varley; LeAnn Radcliffe; Eric Suhler; Dongsoek Choi; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-10       Impact factor: 2.890

3.  From the Center for Disease Control. Isolation of nontuberculous mycobacteria in the United States, 1979.

Authors:  R C Good
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

Review 4.  Nontuberculous mycobacteria in the environment.

Authors:  Joseph O Falkinham
Journal:  Clin Chest Med       Date:  2002-09       Impact factor: 2.878

5.  Environmental risk factors for infection with Mycobacterium avium complex.

Authors:  Carrie Reed; C Fordham von Reyn; Sandra Chamblee; Tedd V Ellerbrock; Johnny W Johnson; Bryan J Marsh; Linda S Johnson; Robert J Trenschel; C Robert Horsburgh
Journal:  Am J Epidemiol       Date:  2006-05-04       Impact factor: 4.897

6.  The antioxidant mimetic, MnTE-2-PyP, reduces intracellular growth of Mycobacterium abscessus.

Authors:  Rebecca E Oberley-Deegan; Young Min Lee; G Eli Morey; Danielle M Cook; Edward D Chan; James D Crapo
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

7.  Opportunistic pathogens enriched in showerhead biofilms.

Authors:  Leah M Feazel; Laura K Baumgartner; Kristen L Peterson; Daniel N Frank; J Kirk Harris; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-14       Impact factor: 11.205

8.  Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease.

Authors:  Joseph O Falkinham
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

9.  Nontuberculous mycobacterial disease following hot tub exposure.

Authors:  E J Mangione; G Huitt; D Lenaway; J Beebe; A Bailey; M Figoski; M P Rau; K D Albrecht; M A Yakrus
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005.

Authors:  Megan E Billinger; Kenneth N Olivier; Cecile Viboud; Ruben Montes de Oca; Claudia Steiner; Steven M Holland; D Rebecca Prevots
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more
  64 in total

1.  Natural disasters and nontuberculous mycobacteria: a recipe for increased disease?

Authors:  Jennifer R Honda; Jon N Bernhard; Edward D Chan
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 2.  Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.

Authors:  Kevin L Winthrop; Michael Iseman
Journal:  Nat Rev Rheumatol       Date:  2013-06-25       Impact factor: 20.543

3.  Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.

Authors:  Jennifer Adjemian; Kenneth N Olivier; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

4.  Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.

Authors:  D Rebecca Prevots; Jennifer Adjemian; Aisling G Fernandez; Michael R Knowles; Kenneth N Olivier
Journal:  Ann Am Thorac Soc       Date:  2014-09

Review 5.  Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.

Authors:  Zohra Prasla; Roy L Sutliff; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

6.  Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Authors:  Eva P Szymanski; Janice M Leung; Cedar J Fowler; Carissa Haney; Amy P Hsu; Fei Chen; Priya Duggal; Andrew J Oler; Ryan McCormack; Eckhard Podack; Rebecca A Drummond; Michail S Lionakis; Sarah K Browne; D Rebecca Prevots; Michael Knowles; Gary Cutting; Xinyue Liu; Scott E Devine; Claire M Fraser; Hervé Tettelin; Kenneth N Olivier; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

7.  Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

Authors:  Meghan E McGarry; John M Neuhaus; Dennis W Nielson; Ngoc P Ly
Journal:  Pediatr Pulmonol       Date:  2019-05-29

8.  Hospital costs in the US for pulmonary mycobacterial diseases.

Authors:  Mehdi Mirsaeidi; Mary Beth Allen; Golnaz Ebrahimi; Dean Schraufnagel
Journal:  Int J Mycobacteriol       Date:  2015-09

9.  The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Authors:  Sara E Strollo; Jennifer Adjemian; Michael K Adjemian; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2015-10

Review 10.  Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights.

Authors:  Pamela J McShane; Jeffrey Glassroth
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.